Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jelle Adelmeijer

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Thrombosis Research|November 5, 2020
Preanalytical variables affect thrombomodulin-modified thrombin generation in healthy volunteersTon Lisman, Jelle Adelmeijer
Hepatology (Baltimore, Md.)|August 5, 2014
Decreased in vitro anticoagulant potency of Rivaroxaban and Apixaban in plasma from patients with cirrhosisWilma Potze, Jelle Adelmeijer, Ton Lisman
Journal of Thrombosis and Haemostasis : JTH|February 28, 2026
"Effect of direct oral anticoagulants in cirrhosis: an in vitro study": comment by Elvers et alFynn L Elvers, Jelle Adelmeijer, Ton Lisman
Thrombosis Research|March 10, 2015
Preserved clot formation detected by the Thrombodynamics analyzer in patients with cirrhosisWilma Potze, Jelle Adelmeijer, Robert J Porte, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|September 6, 2021
Aprotinin Inhibits Thrombin Generation by Inhibition of the Intrinsic Pathway, but is not a Direct Thrombin InhibitorTon Lisman, Jelle Adelmeijer, Dana Huskens, et al.
Blood|July 10, 2008
The glycoprotein Ib-IX-V complex contributes to tissue factor-independent thrombin generation by recombinant factor VIIa on the activated platelet surfaceCees Weeterings, Philip G de Groot, Jelle Adelmeijer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 10, 2003
Enhancement of fibrinolytic potential in vitro by anticoagulant drugs targeting activated factor X, but not by those inhibiting thrombin or tissue factorTon Lisman, Jelle Adelmeijer, H Karel Nieuwenhuis, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 17, 2005
Glycoprotein Ibalpha-mediated platelet adhesion and aggregation to immobilized thrombin under conditions of flowCees Weeterings, Jelle Adelmeijer, Timothy Myles, et al.
Blood|November 1, 2003
Recombinant factor VIIa restores aggregation of alphaIIbbeta3-deficient platelets via tissue factor-independent fibrin generationTon Lisman, Jelle Adelmeijer, Harry F G Heijnen, et al.
Journal of Thrombosis and Haemostasis : JTH|November 3, 2021
Persistent endotheliopathy in the pathogenesis of long COVID syndrome: Comment from von Meijenfeldt et alFien A von Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Thrombosis Research|November 5, 2020
Preanalytical variables affect thrombomodulin-modified thrombin generation in healthy volunteersTon Lisman, Jelle Adelmeijer
Hepatology (Baltimore, Md.)|August 5, 2014
Decreased in vitro anticoagulant potency of Rivaroxaban and Apixaban in plasma from patients with cirrhosisWilma Potze, Jelle Adelmeijer, Ton Lisman
Journal of Thrombosis and Haemostasis : JTH|February 28, 2026
"Effect of direct oral anticoagulants in cirrhosis: an in vitro study": comment by Elvers et alFynn L Elvers, Jelle Adelmeijer, Ton Lisman
Thrombosis Research|March 10, 2015
Preserved clot formation detected by the Thrombodynamics analyzer in patients with cirrhosisWilma Potze, Jelle Adelmeijer, Robert J Porte, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|September 6, 2021
Aprotinin Inhibits Thrombin Generation by Inhibition of the Intrinsic Pathway, but is not a Direct Thrombin InhibitorTon Lisman, Jelle Adelmeijer, Dana Huskens, et al.
Blood|July 10, 2008
The glycoprotein Ib-IX-V complex contributes to tissue factor-independent thrombin generation by recombinant factor VIIa on the activated platelet surfaceCees Weeterings, Philip G de Groot, Jelle Adelmeijer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 10, 2003
Enhancement of fibrinolytic potential in vitro by anticoagulant drugs targeting activated factor X, but not by those inhibiting thrombin or tissue factorTon Lisman, Jelle Adelmeijer, H Karel Nieuwenhuis, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 17, 2005
Glycoprotein Ibalpha-mediated platelet adhesion and aggregation to immobilized thrombin under conditions of flowCees Weeterings, Jelle Adelmeijer, Timothy Myles, et al.
Blood|November 1, 2003
Recombinant factor VIIa restores aggregation of alphaIIbbeta3-deficient platelets via tissue factor-independent fibrin generationTon Lisman, Jelle Adelmeijer, Harry F G Heijnen, et al.
Journal of Thrombosis and Haemostasis : JTH|November 3, 2021
Persistent endotheliopathy in the pathogenesis of long COVID syndrome: Comment from von Meijenfeldt et alFien A von Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer, et al.
Pageof 9